Skip to main content

Gossamer Bio, Inc S-3, filed Nov 16, 2026

Gossamer Bio, Inc. (GOSS)

Gossamer Bio, Inc. registered up to 1,697,363 common shares issuable upon exercise of warrants issued in the June 4, 2026 early settlement of its 5.00% Convertible Senior Notes due 2027; the company will receive no sale proceeds. AI summary

S-3 2026-11-16
View Original
Added on November 16, 2026